INSMED INC Amortization of Debt Issuance Costs and Discounts
INSMED INC (INSM) reported Amortization of Debt Issuance Costs and Discounts of $2.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-06
- INSMED INC amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $1.43M, a 14.74% decline year-over-year.
- INSMED INC amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $1.38M, a 24.15% decline year-over-year.
- INSMED INC amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $1.38M, a 21.28% decline year-over-year.
- INSMED INC amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $1.34M, a 9.63% decline year-over-year.
- INSMED INC amortization of debt issuance costs and discounts for fiscal 2025 was $6.22M, a 9.70% decline from fiscal 2024.
- INSMED INC amortization of debt issuance costs and discounts for fiscal 2024 was $6.88M, a 5.96% decline from fiscal 2023.
- INSMED INC amortization of debt issuance costs and discounts for fiscal 2023 was $7.32M, a 83.41% increase from fiscal 2022.
- INSMED INC amortization of debt issuance costs and discounts for fiscal 2022 was $3.99M.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.81M 10-Q · filed 2026-08-06 | $4.19M derived: sum of 3 quarters · filed 2026-08-06 | $5.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.38M 10-Q · filed 2026-05-07 | $2.76M derived: sum of 2 quarters · filed 2026-05-07 | $4.10M derived: sum of 3 quarters · filed 2026-05-07 | $5.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.72M derived: sum of 2 quarters · filed 2026-02-19 | $4.39M derived: sum of 3 quarters · filed 2026-08-06 | $6.22M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.02M derived: sum of 2 quarters · filed 2026-08-06 | $4.84M 10-Q · filed 2025-10-30 | $6.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.50M 10-Q · filed 2026-08-06 | $5.25M derived: sum of 3 quarters · filed 2026-08-06 | $6.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.82M 10-Q · filed 2026-05-07 | $3.57M derived: sum of 2 quarters · filed 2026-05-07 | $5.05M derived: sum of 3 quarters · filed 2026-05-07 | $6.86M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.23M derived: sum of 2 quarters · filed 2026-02-19 | $5.03M derived: sum of 3 quarters · filed 2026-02-19 | $6.88M 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.29M derived: sum of 2 quarters · filed 2025-10-30 | $5.14M 10-Q · filed 2025-10-30 | $6.89M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.65M 10-Q · filed 2025-08-07 | $5.40M derived: sum of 3 quarters · filed 2026-02-19 | $7.24M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.85M 10-Q · filed 2025-05-08 | $3.60M derived: sum of 2 quarters · filed 2026-02-19 | $5.44M derived: sum of 3 quarters · filed 2026-02-19 | $7.45M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.59M derived: sum of 2 quarters · filed 2026-02-19 | $5.60M derived: sum of 3 quarters · filed 2026-02-19 | $7.32M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $3.84M derived: sum of 2 quarters · filed 2024-10-31 | $5.57M 10-Q · filed 2024-10-31 | $7.09M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.73M 10-Q · filed 2024-08-08 | $5.25M derived: sum of 3 quarters · filed 2025-02-20 | $6.08M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.72M 10-Q · filed 2024-05-09 | $3.25M derived: sum of 2 quarters · filed 2025-02-20 | $4.07M derived: sum of 3 quarters · filed 2025-02-20 | $4.89M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.35M derived: sum of 2 quarters · filed 2025-02-20 | $3.17M derived: sum of 3 quarters · filed 2025-02-20 | $3.99M 10-K · filed 2025-02-20 |
| 2022-09-30 | $822.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $1.64M derived: sum of 2 quarters · filed 2023-10-26 | $2.46M 10-Q · filed 2023-10-26 | |
| 2022-06-30 | $821.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.64M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $822.00K 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $8.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $16.80M derived: sum of 2 quarters · filed 2022-10-27 | $22.05M 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $7.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $13.20M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $5.26M 10-Q · filed 2022-05-05 | |||
| 2017-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $61.00K 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | $31.00K 10-Q · filed 2017-05-03 | |||
| 2016-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $212.00K derived: sum of 2 quarters · filed 2017-08-03 | $250.00K 10-Q · filed 2016-11-03 | $365.00K derived: sum of 4 quarters · filed 2017-08-03 |
| 2016-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $75.00K 10-Q · filed 2017-08-03 | $190.00K derived: sum of 3 quarters · filed 2017-08-03 | $304.00K derived: sum of 4 quarters · filed 2017-08-03 |
| 2016-03-31 | $38.00K 10-Q · filed 2017-05-03 | $153.00K derived: sum of 2 quarters · filed 2017-05-03 | $267.00K derived: sum of 3 quarters · filed 2017-05-03 | $390.00K derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $229.00K derived: sum of 2 quarters · filed 2016-11-03 | $352.00K derived: sum of 3 quarters · filed 2016-11-03 | $458.00K 10-K · filed 2016-02-25 |
| 2015-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $237.00K derived: sum of 2 quarters · filed 2016-11-03 | $343.00K 10-Q · filed 2016-11-03 | $450.00K derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $229.00K 10-Q · filed 2016-08-04 | $336.00K derived: sum of 3 quarters · filed 2016-08-04 | $427.00K derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | $106.00K 10-Q · filed 2016-05-05 | $213.00K derived: sum of 2 quarters · filed 2016-05-05 | $304.00K derived: sum of 3 quarters · filed 2016-05-05 | $394.00K derived: sum of 4 quarters · filed 2016-05-05 |
| 2014-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $198.00K derived: sum of 2 quarters · filed 2016-02-25 | $288.00K derived: sum of 3 quarters · filed 2016-02-25 | $390.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $181.00K derived: sum of 2 quarters · filed 2015-11-06 | $283.00K 10-Q · filed 2015-11-06 | $360.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $192.00K 10-Q · filed 2015-08-06 | $269.00K derived: sum of 3 quarters · filed 2016-02-25 | $289.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $102.00K 10-Q · filed 2015-05-07 | $179.00K derived: sum of 2 quarters · filed 2016-02-25 | $199.00K derived: sum of 3 quarters · filed 2016-02-25 | $317.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $97.00K derived: sum of 2 quarters · filed 2016-02-25 | $215.00K derived: sum of 3 quarters · filed 2016-02-25 | $333.00K 10-K · filed 2016-02-25 |
| 2013-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $138.00K derived: sum of 2 quarters · filed 2014-11-06 | $256.00K 10-Q · filed 2014-11-06 | $437.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $236.00K 10-Q · filed 2014-08-06 | $417.00K derived: sum of 3 quarters · filed 2015-02-27 | |
| 2013-03-31 | $118.00K 10-Q · filed 2014-05-08 | $299.00K derived: sum of 2 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $236.00K 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $55.00K 10-Q · filed 2013-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |